Crossmark

Gastrointestinal symptoms in neuronal ceroid lipofuscinoses (NCLs): an observational study on prevalence, timing of progression, and impact on quality of life

Crossref DOI link: https://doi.org/10.1007/s10048-025-00871-2

Published Online: 2025-12-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Della Vecchia, Stefania

Simonati, Alessandro

Manca, Maria Laura

Pietrafusa, Nicola

Trivisano, Marina

Calabrese, Costanza

Specchio, Nicola

Santorelli, Filippo Maria

,
Funding

Funding for this research was provided by:

Ministero della Salute (Ricerca Corrente 2024)
License Information

Text and Data Mining valid from 2025-12-11

Version of Record valid from 2025-12-11
More Information

Article History

Received: 18 September 2025

Accepted: 26 November 2025

First Online: 11 December 2025

Declarations

:

: This study was approved by the Regione Toscana Pediatric Ethics Committee (CEPR code 130/2024; amendment code 198/2024) and was registered on ClinicalTrials.gov (NCT06844877).

: Written informed consent was obtained from all participants or their legal guardians. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below